The central mechanisms underlying salt-sensitive hypertension, a significant public health issue, remain to be established. Researchers in our laboratory have reported that hypothalamic paraventricular nucleus (PVN) G i 2 proteins mediate the sympathoinhibitory and normotensive responses to high sodium intake in salt-resistant rats. Given the recent evidence of central inflammation in animal models of hypertension, we hypothesized that PVN inflammation contributes to G i 2 protein-dependent, salt-sensitive hypertension. Male Sprague-Dawley rats received chronic intracerebroventricular infusions of a targeted G i 2 or control scrambled oligodeoxynucleotide (ODN) and were maintained for 7 days on a normal-salt (NS; 0.6% NaCl) or high-salt (HS; 4% NaCl) diet; in subgroups on HS, intracerebroventricular minocycline (microglial inhibitor) was co-infused with ODNs. Radiotelemetry was used in subgroups of rats to measure mean arterial pressure (MAP) chronically. In a separate group of rats, plasma noradrenaline, plasma renin activity, urinary angiotensinogen and mRNA levels of the PVN pro-inflammatory cytokines TNF , IL-1 and IL-6 and the anti-inflammatory cytokine IL-10 were assessed. In additional groups, immunohistochemistry was performed for markers of PVN and subfornical organ microglial activation and cytokine levels and PVN astrocyte activation. High salt intake evoked salt-sensitive hypertension, increased plasma noradrenaline, PVN pro-inflammatory cytokine mRNA upregulation, anti-inflammatory cytokine mRNA downregulation and PVN-specific microglial activation in rats receiving a targeted G i 2 but not scrambled ODN. Minocycline co-infusion significantly attenuated the increase in MAP and abolished the increase in plasma noradrenaline and inflammation in G i 2 ODN-infused animals on HS. Our data suggest that central G i 2 protein prevents microglial-mediated PVN inflammation and the development of salt-sensitive hypertension.
INTRODUCTION
Hypertension is one of the most significant public health issues in the USA; according to 2017 American Heart Association guidelines, it is estimated that one in two people are hypertensive (Reboussin et al., 2018) . Furthermore, hypertension is the leading cause of chronic kidney disease, stroke and ischaemic heart disease (Lloyd-Jones et al., 2010; Mozaffarian et al., 2016) .
Excess dietary sodium intake, which can drive the salt sensitivity of blood pressure and increase the risk of developing hypertension, is of great public health significance, because the average American is consuming almost three times the daily sodium intake recommended by the American Heart Association (Lloyd-Jones et al., 2010) .
Researchers in our laboratory have previously shown that in salt-resistant animals, upregulation of the G-protein-coupled receptor -i 2 subunit (G i 2 ) protein in the paraventricular nucleus (PVN) of the hypothalamus of salt-resistant rats mediates high dietary sodium-evoked sympathoinhibitory responses to facilitate normotension and the maintenance of salt resistance (Kapusta, Pascale, Kuwabara, & Wainford, 2013; Wainford, Carmichael, Pascale, & Kuwabara, 2015) . In contrast, hypertensive Dahl salt-sensitive (DSS) rats fail to upregulate PVN G i 2 proteins in response to high dietary sodium intake . Restoration of the upregulation of G i 2 proteins in the DSS rat via the use of the 8congenic rat line attenuated the magnitude of DSS hypertension . Thus, PVN G i 2 upregulation in response to high dietary sodium intake is crucial for the maintenance of salt resistance.
Several recent studies have suggested that central inflammatory processes contribute to the development of hypertension, and include the upregulation of pro-inflammatory cytokines (PICs) such as tumour necrosis factor-(TNF ), interleukin (IL)-6 and IL-1 (Jiang et al., 2018; Shi et al., 2010 Shi et al., , 2011 . Furthermore, these processes have been shown to feature downregulation of the antiinflammatory cytokine IL-10 (Segiet, Smykiewicz, Kwiatkowski, & Zera, 2019) . Inflammatory processes have also been demonstrated to mediate neuronal excitability and even influence the firing rates of neurons, potentially disrupting neural homeostasis (Galic, Riazi, & Pittman, 2012; Shi et al., 2011) . Glial cells, including microglia and astrocytes, can become activated in response to a pathological stimulus and have been demonstrated to produce inflammatory cytokines and reactive oxygen species and to disrupt neural homeostasis (Biancardi, Stranahan, Krause, de Kloet, & Stern, 2016; Wolf, Boddeke, & Kettenmann, 2017) . Therefore, we hypothesized that central inflammatory processes, involving activation of microglia and astrocytes, contribute to the development of G i 2 protein-dependent, salt-sensitive hypertension. To test this hypothesis, we used a male
Sprague-Dawley rat model infused centrally with either a scrambled (SCR) control oligodeoxynucleotide (ODN) or targeted G i 2 ODN alone or in combination with centrally administered minocycline, during a challenge with either a normal-or high-salt diet. In these
New Findings
• What is the central question of this study?
We hypothesized that central inflammatory processes that involve activation of microglia and astrocytes contribute to the development of G i 2 proteindependent, salt-sensitive hypertension.
• What is the main finding and its importance?
The main finding is that PVN-specific inflammatory processes, driven by microglial activation, appear to be linked to the development of G i 2 protein-dependent, salt-sensitive hypertension in Sprague-Dawley rats. This finding might reveal new mechanistic targets in the treatment of hypertension.
animals, we assessed many markers of central inflammation via mRNA and immunohistochemical approaches.
METHODS

Ethical approval
All animal protocols were approved by the Institutional Animal Care and Use Committee under protocol number AN15241, in accordance with the guidelines of the Boston University School of Medicine and the US National Institutes of Health Guide for the Care and Use of Laboratory Animals, 8th edition (2011). Please note that all possible steps were taken to minimize pain and suffering, and euthanasia was conducted in accordance with approved protocols. We used decapitation in a small, clearly defined subset of animals, in which we were measuring basal concentrations of plasma noradrenaline, which are suppressed by the administration of sedatives and anaesthetics.
Our studies comply fully with the ethical principles and animal ethics checklist of Experimental Physiology.
Animals
Male Sprague-Dawley rats weighing 275-300 g were purchased from (Brouwers, Smolders, Wainford, & Dupont, 2015; Frame, Carmichael, Kuwabara, Cunningham, & Wainford, 2019; Wainford et al., 2015) .
Intracerebroventricular oligodeoxynucleotide infusion
Chronic downregulation of brain G i 2 proteins was achieved by continuous I.C.V. infusion of a phosphodiesterase ODN probe that selectively and specifically targets G i 2 proteins (5 ′ -CTTGTCGATCATCTTAGA-3 ′ ). Control animals received an I.C.V. infusion of a SCR ODN (5 ′ -GGGCGAAGTAGGTCTTGG-3 ′ ). In these studies, SCR and G i 2 ODNs were dissolved in isotonic saline and infused I.C.V. at 25 µg (5 µl) −1 day −1 , a technique previously reported by researchers in our laboratory selectively to downregulate G i 2 subunit proteins throughout the brain of conscious Sprague-Dawley rats (Kapusta et al., 2013; Kapusta, Pascale, & Wainford, 2012; Wainford et al., 2015) . Several publications from our laboratory have confirmed effective (∼85%) ODN-mediated downregulation of G i 2 protein expression after chronic I.C.V. ODN infusion as assessed by western blotting (Kapusta et al., 2013; Wainford et al., 2015) .
To achieve I.C.V. ODN infusion, animals were anaesthetized (ketamine, 30 mg kg −1 I.P. in combination with xylazine, 3 mg kg −1 I.P.) and implanted stereotaxically with a stainless-steel cannula into the right lateral cerebral ventricle (Plastics One Inc., Roanoke, VA, USA), which was connected via Silastic tubing to a osmotic minipump (model 2004; Durect Corporation, Cupertino, CA, USA) .
A National Center for Biotechnology Information (NCBI) Basic
Local Alignment Search Tool (BLAST) search of the Rattus norvegicus
Reference Sequence (RefSeq) protein database was conducted to confirm: (i) the specificity of the G i 2 ODN for the G i 2 rat protein sequence; and (ii) that the SCR ODN does not match any known rat protein sequence. In addition, our prior studies (Kapusta et al., 2012 (Kapusta et al., , 2013 Wainford et al., 2015) and the studies from other laboratories examining the effects of opioid analgesia and opioid-induced feeding (Hadjimarkou, Silva, Rossi, Pasternak, & Bodnar, 2002; Rossi, Standifer, & Pasternak, 1995; Silva et al., 2000; Standifer, Rossi, & Pasternak, 1996) have demonstrated the selectivity and specificity of this G i 2 ODN sequence in the downregulation of brain G i 2 proteins in rats.
Intracerebroventricular minocycline and oligodeoxynucleotide co-infusion
Chronic downregulation of brain G i 2 proteins during microglial inhibition was achieved by continuous I.C.V. infusion of an ODN probe that targets G i 2 proteins, as described above, in combination with I.C.V. minocycline infusion. In these studies, SCR and G i 2 ODNs were dissolved in isotonic saline and infused I.C.V. at 25 µg (5 µl) −1 day −1 in combination with minocycline at a rate of 25 µg (5 µl) −1 day −1 (Shi et al., 2010 ).
Experimental approaches
Dietary sodium intake
After I.C.V. osmotic minipump implantation, animals were randomly assigned to a normal-salt (0.6% NaCl) or high-salt (4% NaCl) diet for a period of 7 days. At the end of the 7 day experimental period, animals were either killed by conscious decapitation or received ketamine anaesthesia (ketamine, 30 mg kg −1 I.P.) before undergoing cardiac perfusion.
Chronic blood pressure measurement
In certain studies, radiotelemetry was used for the chronic measurement of blood pressure. Data were collected via scheduled sampling for 10 s every 10 min in all groups of rats. Rats were maintained on a normal-salt diet (0.6% NaCl) for a 5 day baseline period and were then randomly assigned (n = 6 per group) to either a normal-salt (0.6% total NaCl) or high-salt (4% total NaCl) diet, and blood pressure was recorded for a further 7 days.
Plasma renin activity, urinary angiotensinogen and noradrenaline assays
Plasma renin activity (PRA), urinary angiotensinogen and plasma noradrenaline (NA) concentrations were determined as previously described (Kapusta et al., 2012; Wainford et al., 2015) .
In brief, after plasma extraction, from blood samples obtained after conscious decapitation, samples were frozen at −80 • C until later analysis. For the PRA assay, samples were analysed using a plasma renin activity enzyme-linked immunosorbent assay F I G U R E 1 Impact of control scrambled (SCR) and targeted G i 2 intracerebroventricular oligodeoxynucleotide (ODN) infusion [25 µg (5 µl) −1 day −1 for 7 days] and minocycline (MINO)-ODN co-infusion [ODN, 25 µg (5 µl) −1 day −1 ; MINO: 120 µg day −1 for 7 days in high-salt (HS) group only] in male Sprague-Dawley rats receiving 7 days of normal-salt (NS; 0.6% NaCl) or HS (4% NaCl) diets on: (a,b) mean arterial pressure (MAP) as assessed via radiotelemetry over 5 days preceding the experimental diet and the 7 days of the experimental diet; (c) plasma noradrenaline (NA) concentrations; (d) urinary angiotensinogen (UAGT) concentrations; and (e) plasma renin activity. (n = 6 per group, * P < 0.05 versus pre-experimental diet NS in respective ODN treatment group; P < 0.05 versus 7 days of experimental HS in respective ODN treatment group; P < 0.05 versus 7 days of experimental NS diet in the respective ODN treatment group, means ± SD.)
Cytokine mRNA studies
On day 7, a subset of animals (n = 6 per group) was sacrificed via conscious decapitation and whole blood was collected for analysis.
Fresh frozen brains were harvested, and a tissue punching tool was used to take bilateral PVN punches (Kapusta et al., 2012 (Kapusta et al., , 2013 .
Total RNA was isolated using RNeasy kits (Qiagen) according to the manufacturer's instructions, and 200 ng of purified RNA was reverse transcribed with a high-capacity complementary DNA reverse transcription kit (Qiagen, Hilden, Germany). The IL-1 , IL-6, TNF and IL-10 mRNA levels were analysed by quantitative real-time PCR using specific primers and probes in a PRISM 7000 sequence detection system (Applied Biosystems, Bedford, MA, USA) (Shi et al., 2010) . Data were normalized to 18S ribosomal RNA, and the 2 −ΔΔCT method was used to calculate relative changes in gene expression (Zuriaga et al., 2017 ).
Measurement of brain G i 2 protein levels
After completion of experimental protocols, the rats were killed via conscious decapitation, and whole brains were removed from subsets of animals co-infused with both SCR and G i 2 ODN-minocycline, and frozen at −80 • C. Paraventricular nucleus samples were extracted from frozen brains cut on a cryostat using a brain punch tool (Stoelting Co., Wood Dale, IL, USA) as previously described (Kapusta et al., 2012; Wainford et al., 2015; . Tissue lysates were prepared and protein levels quantified using the BCA assay according to the manufacturer's instructions F I G U R E 2 (a) Representative immunoblot demonstrating impact of G i 2 oligodeoxynucleotide (ODN)-minocycline co-infusion on paraventricular nucleus (PVN) G i 2 protein expression. L1 and L2 are ladder, S1-S6 are protein extracts from the PVN of scrambled control (SCR) ODN-minocycline co-infused animals, and G1-G6 are protein extracts from the PVN of G i 2 ODN-minocycline co-infused animals. (b) Representative Coomassie Blue-stained gel demonstrating total protein loaded, and bands outlined in yellow for normalization of bands in (a). (c) Quantification of the fold change in PVN G i 2 protein expression between SCR ODN-minocycline co-infused animals on high salt (HS) diet (4% NaCl) and G i 2 ODN-minocycline co-infused animals on HS diet. (n = 6 per group, * P < 0.05 versus SCR ODN treatment group, mean ± SD.) (Thermo Scientific, Waltham, MA, USA). Lysates were resolved on a 10% SDS-PAGE gel and transferred to nitrocellulose membrane (catalogue no. 456-1033; Bio-Rad, Hercules, CA, USA). G i 2 levels were determined as previously published by our laboratory (Kapusta et al., 2012; Wainford et al., 2015) using commercially available antibodies purchased from Santa Cruz Biotechnologies (Santa Cruz, CA, USA), directed against G i 2 (Santa Cruz Biotechnology catalogue no.
sc-13534, 1:200, RRID:AB_627644); protein levels were normalized to total protein via Coomassie Blue-stained gels. Chemiluminescent immunoreactive bands were detected by a horseradish peroxidaseconjugated secondary antibody; data were imaged and semi-quantified using Bio-Rad Quantity One image analysis software.
Immunohistochemistry
Brain tissue from transcardially perfused animals was post-fixed for 24 h in 4% paraformaldehyde and then for 72 h in 30% sucrose before being sliced on a cryostat. Slices 40 µm thick were obtained, and immunohistochemistry was performed in six-well plates. Slices of the
PVN were selected based on coordinates from Paxinos & Watson
The Rat Brain atlas (Paxinos & Watson, 2007) 
Sholl analysis of microglia
Images of level 2 of the PVN at ×40 magnification were obtained as previously described. Images were blinded and shuffled, and 
Analysis of astrocytes
Astrocytes were analysed using ImageJ software, in which the images were converted to a greyscale and set to 'Image → Type → RGB' and then analysis was performed to quantify the total percentage area of the PVN that the astrocytes composed, i.e. their density in the PVN. Astrocytes stained for GFAP, which is purportedly upregulated in astrogliosis (Pekny, Wilhelmsson, & Pekna, 2014) , were quantified (in pixels) and divided by the total number of pixels composing the PVN to obtain a percentage of composition, or tissue density.
Cytokine immunohistochemistry
Cytokine immunohistochemistry was analysed qualitatively for visible differences in stain immunoreactivity in both the PVN and the SFO. 
Statistical analysis
Data are expressed as means ± SD. Differences occurring between treatment groups (e.g. SCR versus G i 2 ODN) were assessed by a two- 
RESULTS
Impact of brain G i 2 protein downregulation during 7 days of high salt intake on plasma NA
In control SCR ODN-infused male Sprague-Dawley rats, HS diet for 7 days had no impact on MAP and evoked global sympathoinhibition (SCR ODN; plasma NA: NS 65 ± 5 versus HS 37 ± 6 nmol l −1 , P < 0.05; Figure 1 ). In contrast, male Sprague-Dawley rats receiving a targeted G i 2 ODN infusion, which selectively downregulates brain G i 2 proteins, developed salt-sensitive hypertension (G i 2 ODN; MAP day 7 of HS diet: NS 103 ± 1.1 versus HS 128 ± 2 mmHg, P < 0.05) and
dietary sodium-evoked sympathoexcitation, measured as plasma NA (G i 2 ODN; plasma NA: NS 67 ± 6 versus HS 91 ± 8 nmol l −1 , P < 0.05).
Additionally, in these hypertensive rats we observed suppression of plasma renin activity and urinary angiotensinogen to the same levels as those seen in SCR ODN-infused rats (Figure 1) . In control SCR ODN- (G i 2 ODN; plasma NA: HS 91 ± 8 versus HS+MINO 72 ± 6 nmol l −1 , P < 0.05; Figure 1c ).
Impact of minocycline on G i 2 ODN-mediated downregulation of PVN G i 2 proteins
In subsets of animals co-infused with ODN and minocycline, immunoblotting was performed to assess the impact of co-infusion of minocycline and ODNs on targeted G i 2 protein downregulation. The G i 2 ODN-MINO co-infusion resulted in an average 79% reduction in PVN-specific G i 2 protein expression as assessed by immunoblotting, normalized to total protein in Coomassie Blue-stained gels (Figure 2 ; SCR ODN fold change HS + MINO 1.04 ± 0.24 versus G i 2 HS + MINO 0.209 ± 0.12, P < 0.0001). Therefore, minocycline did not appear to have an impact on the ability of the ODN to induce protein knockdown successfully.
Impact of brain G i 2 protein downregulation during 7 days of high salt intake on PVN inflammatory cytokine levels
In control SCR ODN-infused male Sprague-Dawley rats, 7 days of HS diet had no impact on the PVN mRNA expression of the proinflammatory cytokines IL-1 , IL-6 and TNF or the anti-inflammatory cytokine IL-10 ( Figure 3) . In contrast, in male Sprague-Dawley rats receiving a targeted G i 2 ODN infusion, which develop salt-sensitive hypertension (Figure 1a) , dietary sodium evoked a ∼2to 2.5-fold increase (P < 0.05) in the PVN mRNA levels of the pro-inflammatory cytokines IL-1 , IL-6 and TNF (Figure 3a-c) . Additionally, in these same rats, we observed suppression of PVN mRNA expression of the anti-inflammatory cytokine IL-10 ( Figure 3d ). In control SCR ODN-infused rats maintained on 7 days of HS intake, minocycline infusion had no impact on the expression of cytokine mRNA levels In control SCR ODN-infused male Sprague-Dawley rats, 7 days of HS diet had no impact on the PVN protein expression of the pro-inflammatory cytokines IL-1 , IL-6 or TNF as determined via immunohistochemistry (Figures 4-6 ). In these same normotensive SCR ODN-infused animals, 7 days of HS intake increased the immunoreactivity of the anti-inflammatory cytokine IL-10 ( Figure 7) . In contrast, in male Sprague-Dawley rats receiving a targeted G i 2 ODN infusion, which develop salt-sensitive hypertension (Figure 1a ), high salt intake evoked increased protein expression of the proinflammatory cytokines IL-1 and IL-6 but no change in the expression of TNF (Figures 4-6 ). Furthermore, in contrast to the response seen in controlled SCR ODN-infused rats, the HS diet did not increase IL-10 immunoreactivity in G i 2 ODN-infused rats (Figure 7 ). activation (G i 2 ODN; activation of microglia: NS 17 ± 6 versus HS 29 ± 2%, P < 0.05; Figure 9 ). Central minocycline co-infusion in control SCR ODN-infused rats maintained on 7 days of HS intake reduced average microglial density without impacting levels of microglial activation (Figures 8 and 9 ). Significantly, central minocycline coinfusion abolished the HS diet-evoked increase in microglial infiltration and activation in rats receiving a G i 2 ODN infusion (G i 2 ODN; number of microglia: HS 36 ± 7 versus HS + MINO 16 ± 6, P < 0.05; Figure 8 ; activation of microglia: HS 29 ± 2 versus HS + MINO 13 ± 6%, P < 0.05; Figure 9 ).
Impact of brain G i 2 protein downregulation during 7 days of high salt intake on PVN microglia and astrocytes
Sholl analysis of microglia in control SCR ODN-infused male
Sprague-Dawley rats demonstrated that 7 days of HS diet had no impact on PVN microglial branching complexity, because there were no statistically significant differences in the trend lines (Figure 10a ).
In contrast, in hypertensive male Sprague-Dawley rats receiving a targeted G i 2 ODN infusion, the HS diet significantly decreased the branching complexity of microglia, as shown by the decreased number of ring intersections along the entire trend line compared with animals on the NS diet (P < 0.05; Figure 10b ). Central minocycline co-infusion in control SCR ODN-infused rats maintained on 7 days shown by a significant elevation in ring intersections distant from the soma (P < 0.05; Figure 10a ). Significantly, central minocycline co-infusion abolished the HS diet-evoked reduction in microglial branching complexity in rats receiving a G i 2 ODN infusion (P < 0.05; Figure 10b ).
Immunohistochemistry for the astrocytic marker GFAP demonstrated that, in both control SCR and targeted G i 2 ODNinfused rats, the dietary salt intake had no impact on astrocyte density within the PVN (Figure 11 ).
Impact of brain G i 2 protein downregulation during 7 days of high salt intake on SFO microglia and cytokines
Immunohistochemistry for OX-42 (CD11b/c; microglial antigen) demonstrated that 7 days of HS diet had no impact on SFO microglial density, number of active microglia or percentage of active microglia, regardless of ODN infusion (Figure 12 ). Furthermore, minocycline coinfusion had no statistically significant impact on the aforementioned parameters, regardless of ODN infusion. Immunohistochemistry in the subfornical organ suggested that 7 days of HS diet elicited no change in SFO PIC protein levels of IL-6, IL-1 or TNF , or anti-inflammatory cytokine IL-10 protein levels between SCR ODN-infused and G i 2 ODN-infused rats (Figure 13 ).
DISCUSSION
The present study was designed to investigate the potential In agreement with our previous data generated in male Sprague-Dawley rats (Kapusta et al., 2013) , we observed the development of sympathetically mediated salt-sensitive hypertension after the central ODN-mediated downregulation of G i 2 proteins. These data extend our earlier report that G i 2 protein downregulation evokes saltsensitive hypertension after 21 days of 8% NaCl intake (Kapusta et al., 2013) , confirm our data generated in Dahl salt-resistant rats that G i 2 protein downregulation evokes hypertension by day 7 and establish that the salt sensitivity of blood pressure after central downregulation of G i 2 protein develops at a lower, more physiologically relevant dietary intake level (4% NaCl). Owing to the incompatible methods of tissue preparation for immunohistochemistry (paraformaldehyde fixation) and western blotting (snap-freezing) of PVN tissue, it was not possible to validate G i 2 protein knockdown in animals in which microglia and cytokine expression were assessed by immunohistochemistry. However, to determine whether minocycline co-infusion was impacting ODNmediated G i 2 protein downregulation, in separate groups of animals co-infused with G i 2 or SCR ODN and minocycline, we performed immunoblotting of PVN punches. In these animals, minocycline did not impact ODN infusion, and G i 2 ODN infusion successfully reduced PVN G i 2 protein expression by 79%. In certain groups of animals in which we were unable to validate knockdown via western blot, blood pressure and plasma NA concentrations were used as a physiological measure of the development of salt-sensitive hypertension (Carmichael, Carmichael, Kuwabara, Cunningham, & Wainford, 2016; Kapusta et al., 2013; Wainford et al., 2015) . Despite experimental limitations preventing the confirmation of G i 2 protein knockdown, based on our many earlier publications demonstrating the efficacy of our ODN approach to downregulate central G i 2 proteins acutely and chronically, our confirmatory studies presented in minocycline-infused animals, and the clear differences observed in G i 2 versus SCR ODNinfused animals in several inflammatory markers, we are confident that G i 2 knockdown was achieved.
Several studies, conducted in different models of hypertension, including the spontaneously hypertensive rat and the angiotensin II pro-inflammatory cytokines (Bardgett et al., 2014; Biancardi et al., 2016; Shi et al., 2010) . A recent study conducted in the DSS rat model also reported an upregulation of PVN pro-inflammatory cytokines in response to high dietary sodium intake (Jiang et al., 2018) . As such, we elected to investigate the potential role of PVN inflammation in our salt-sensitive G i 2 protein-dependent hypertension model. On day 7 of high salt intake, we observed increased PVN PIC production of IL-6, IL-1 and TNF mRNA. Interestingly, immunohistochemistry for these cytokines in the PVN suggested the increased protein expression of IL-6 and IL-1 only. It is possible that TNF protein levels may be increased only transiently during the development of saltsensitive hypertension and are not required to maintain established hypertension. Alternatively, it is possible that although TNF mRNA is upregulated, the neuroinflammatory response observed after G i 2 protein downregulation is TNF independent, as reported in angiotensin II-dependent hypertension (Bardgett et al., 2014) . At Interleukin-10, an anti-inflammatory cytokine, has previously been shown to be neuroprotective (Shi et al., 2010; Song et al., 2014) .
Levels of IL-10 were downregulated at both the mRNA and protein levels during G i 2 ODN infusion on the HS diet, suggesting a decrease in neuroprotective signalling in the PVN, consistent with literature suggesting that IL-10 is protective against other forms of hypertension (Drews et al., 2019; Segiet et al., 2019) . Lastly, minocycline administration, which lowered blood pressure and plasma NA levels in G i 2 ODN-infused rats on a HS diet, restored mRNA levels of PIC and anti-inflammatory cytokines to baseline, suggesting a direct role of neuroinflammation in G i 2 protein-dependent hypertension.
We speculate that there is an imbalance between anti-inflammatory and pro-inflammatory mechanisms occurring within the PVN that contributes to the development of salt-sensitive hypertension, potentially via modulation of sympathetic outflow, a hypothesis supported by the recent data generated in DSS rats (Jiang et al., 2018) .
Given that in our previous study, we reported that an absence of PVN G i 2 protein upregulation during high salt intake in the DSS rat contributes to sympathoexcitation and hypertension , we speculate that impaired PVN G i 2 protein signalling might contribute to PVN inflammation in the Dahl rat phenotype.
To attempt to identify the source of the PICs being produced in the PVN in the setting of G i 2 protein-dependent salt-sensitive hypertension, we investigated the involvement of microglia and astrocytes. We elected to examine these as potential mediators of the observed increase in PICs because both microglia (innate immune cells in brain that are tightly linked to the production of PICs; Galic et al., 2012; Shi et al., 2010) and astrocytes (regulators of CNS inflammation; Colombo & Farina, 2016; Pekny et al., 2014) become activated in response to pathological stimuli (e.g. hypertension).
Our immunohistochemical analysis revealed no impact of central production and G i 2 protein-dependent salt-sensitive hypertension, future studies, beyond the scope of the present investigations, will assess the time course of microglial activation, PIC production and development of hypertension. Additionally, we have not characterized the impact of minocycline on PVN neuron excitability electrophysiologically. It is possible that minocycline, which has been demonstrated in subpopulations of neurons to modulate excitability (Liu, Zhang, Zhu, Luo, & Liu, 2015) , operates independently of microglia to decrease the intrinsic excitability of PVN presympathetic neurons.
Collectively, these data indicate that G i 2 protein signal transduction is a novel CNS mechanism that influences PVN inflammation in response to a chronic HS challenge to counter the development and magnitude of sympathetically mediated salt-sensitive hypertension.
Our present findings also suggest a potential role of G i 2 protein signalling in countering PVN inflammatory processes during HS intake to prevent the development of salt-sensitive hypertension. Given that we observed attenuated plasma NA and reductions in PIC and MAP after minocycline infusion, we speculate that microgliosis contributes significantly to G i 2 protein-dependent salt-sensitive hypertension.
Our data add to our understanding of the CNS inflammatory pathways influencing blood pressure regulation and contribute to the growing body of evidence that PVN PIC pathways have a direct influence on sympathetic outflow (Shi et al., 2011) . Increased understanding of the PVN inflammatory responses to elevations in dietary salt intake has implications for the development of salt-sensitive hypertension.
We speculate that PVN neuro-inflammation, mediated by microglial activation, plays a significant role in the pathophysiology of disease states in which sympathoexcitation is evident (e.g. several forms of hypertension, heart failure) and represents a potential therapeutic target. After our report of a positive association between the single nucleotide polymorphism rs10510755 in the human GNAI2 gene and the salt sensitivity of blood pressure, independently of sex or age, in the Genetic Epidemiology of Salt Sensitivity data set (Zhang, Frame, Williams, & Wainford, 2018) , our data have translational implications for the development of personalized anti-hypertensive therapeutics designed to target G i 2 protein-gated pathways.
